0125 GMT - Sigma Healthcare gets a new bear at Jefferies as its merger with privately owned Chemist Warehouse moves slowly toward the finish line. Analyst David Stanton tells clients in a note that, following the latest update from Australia's competition regulator, he now expects the merger to complete by the end of February. He had previously been eyeing the end of this month. Jefferies raises its fiscal 2025 forecasts for Chemist Warehouse sales and margins, supporting a 16% rise in its target price for Sigma shares to A$1.85. However, the stock's recent advance leads the investment bank to cut its recommendation to underperform from hold. Shares are down 1.95% at A$2.765. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
December 11, 2024 20:25 ET (01:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。